Trials / Unknown
UnknownNCT05239273
Effects of Complex Decongestive Therapy Applied on Patients With Lower Extremity Lymphedema
Investigation of the Effects of Complex Decongestive Therapy Applied on Patients With Lower Extremity Lymphedema on Body Awareness, Functionality and Quality of Life
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Ankara Yildirim Beyazıt University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the effects of complex decongestive therapy applied to patients with lymphedema in the lower extremities on body awareness, functionality and quality of life.
Detailed description
Lymphedema is a chronic condition characterized by the permanent accumulation of protein-rich fluid in certain body regions as a result of the dysfunction of the lymphatic system, in which skin and subcutaneous changes are added to the picture. Pain in the affected extremity and other accompanying lymphedema symptoms can negatively affect functionality and quality of life, and swelling in the extremity can negatively affect the body image of individuals. Today, Complex Decongestive Therapy (CDT) is accepted as the gold standard in the treatment of lymphedema. It has been shown in the literature that CDT has positive effects on parameters such as functionality, quality of life, and balance in patients with upper limb lymphedema. There are few studies investigating the effects of CDT on body awareness, functionality and quality of life in patients who developed lymphedema in the lower extremities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Complex Decongestive Therapy | Phase 1 of CDT will be applied. This application consists of manual lymph drainage, skin care, compression bandage and exercises. |
| OTHER | Control | No intervention |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2022-09-01
- Completion
- 2023-03-01
- First posted
- 2022-02-14
- Last updated
- 2022-02-14
Source: ClinicalTrials.gov record NCT05239273. Inclusion in this directory is not an endorsement.